Pubblicazioni ufficiali Genmab A/S

Azioni

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 17:20:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
1.742 ^DKK	+1,34%		-2,71%	-19,14%

28/06	La terapia per il linfoma di Genmab e AbbVie raccomandata per l'approvazione nell'UE	MT
28/06	AbbVie, Genmab ricevono un parere europeo positivo sull'autorizzazione all'immissione in commercio per un possibile trattamento del linfoma	MT

Acquisition	21/05	CO
Share buyback	06/05	CO
1st quarter results	02/05	CO
Share buyback	22/04	CO
Share buyback	15/04	CO
Share buyback	08/04	CO
Share buyback	02/04	CO
Share buyback	25/03	CO
Minutes of the general assembly	13/03	CO
Share buyback	11/03	CO
Share buyback	04/03	CO
Mixed general shareholder meeting	15/02	CO
Share buyback	14/02	CO
Annual ESG Report	14/02	CO
Annual Report	14/02	CO
Annual Report	14/02	CO
3rd quarter results	07/11	CO
Admission of new securities	15/08/23	CO
1st-half-year results	03/08/23	CO
1st quarter results	10/05/23	CO
Shareholders meeting voting results	29/03/23	CO
Changes in management and corporate officers	28/03/23	CO
Share buyback	27/03/23	CO
Share buyback	20/03/23	CO
Share buyback	13/03/23	CO